Skip to content

Health Telemonitoring

OTHER7 trials

Sponsors

M.D. Anderson Cancer Center, Fred Hutchinson Cancer Center, Fox Chase Cancer Center, ECOG-ACRIN Cancer Research Group, Mayo Clinic

Conditions

Acute Myeloid LeukemiaBreast CarcinomaHematologic MalignanciesHematopoietic and Lymphatic System NeoplasmHematopoietic and Lymphoid System NeoplasmLocalized Non-Muscle Invasive Bladder Urothelial CarcinomaMalignant Head and Neck NeoplasmMalignant Neoplasm

Phase 3

Unknown Phase

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RecruitingNCT01365169
M.D. Anderson Cancer CenterMalignant Head and Neck Neoplasm, Malignant Neoplasm, Metastatic Malignant Neoplasm in the Neck +45
Start: 2011-05-25End: 2027-06-30Target: 590Updated: 2026-07-15
Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy
TerminatedNCT02226497
Fred Hutchinson Cancer CenterAcute Myeloid Leukemia, Myelodysplastic Syndrome
Start: 2015-01-09End: 2018-08-30Updated: 2020-01-10
SMART Project in Preventing Skin Cancer
CompletedNCT03177057
Fox Chase Cancer CenterSkin Carcinoma
Start: 2013-04-23End: 2014-12-31Updated: 2018-08-01
Mobile Health for Adherence in Breast Cancer Patients
Active, not recruitingNCT06112613
ECOG-ACRIN Cancer Research GroupBreast Carcinoma
Start: 2024-04-02End: 2027-09-22Target: 390Updated: 2026-09-04
A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors
Active, not recruitingNCT06198010
Mayo ClinicHematopoietic and Lymphatic System Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Start: 2024-02-07End: 2027-03-12Updated: 2026-09-02
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
RecruitingNCT07302230
University of WashingtonLocalized Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8 +1
Start: 2026-03-11End: 2027-09-27Target: 100Updated: 2026-07-06

Related Papers